Insider · CIK 0001862728
Kelly Smales
Files at TGAN (Transphorm, Inc.). First filing Nov 21, 2023, latest May 24, 2024.
In brief
Kelly Smales files SEC Form 4 as director at TGAN (Transphorm, Inc.). Since Nov 21, 2023, Kelly Smales has reported 0 open-market buys worth $0 and 9 open-market sells worth $79k, the latest filed on May 24, 2024.
A track record needs three past buys with six months of prices behind them; Kelly Smales has 0, so none is measured yet.
The newest scored trade: sold $20k of TGAN on May 22, 2024, filed May 24, 2024, scored 3 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 3Weak | Transphorm, Inc. | $20k 3,996 shares | -5% | - | |
| 3Weak | Transphorm, Inc. | $2,304 475 shares | -1% | - | |
| 0Weak | Transphorm, Inc. | $3,753 766 shares | -1% | - | |
| 10Weak | Transphorm, Inc. | $19k 3,996 shares | -5% | - | |
| 3Weak | Transphorm, Inc. | $2,271 471 shares | -1% | - | |
| 0Weak | Transphorm, Inc. | $2,987 766 shares | -1% | - | |
| 0Weak | Transphorm, Inc. | $7,895 2,187 shares | -3% | - | |
| 3Weak | Transphorm, Inc. | $10k 3,995 shares | -5% | - | |
| 3Weak | Transphorm, Inc. | $11k 3,883 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 22, 2024 | TGAN Transphorm, Inc. | 3,996 0.01% of outstanding | $20k | May 22, 2024 | $25k |
| Apr 25, 2024 | TGAN Transphorm, Inc. | 475 0.00% of outstanding | $2,279 | Apr 24, 2024 | $23k |
| Apr 5, 2024 | TGAN Transphorm, Inc. | 766 0.00% of outstanding | $3,753 | Apr 4, 2024 | $30k |
| Feb 28, 2024 | TGAN Transphorm, Inc. | 3,996 0.01% of outstanding | $19k | Feb 28, 2024 | $23k |
| Jan 25, 2024 | TGAN Transphorm, Inc. | 471 0.00% of outstanding | $2,270 | Jan 24, 2024 | $21k |
| Jan 4, 2024 | TGAN Transphorm, Inc. | 766 0.00% of outstanding | $2,987 | Jan 4, 2024 | $29k |
| Jan 3, 2024 | TGAN Transphorm, Inc. | 2,187 0.00% of outstanding | $7,895 | Jan 2, 2024 | $21k |
| Nov 24, 2023 | Transphorm Technology, Inc. | 3,995 0.01% of outstanding | $10k | Nov 22, 2023 | $11k |
| Nov 20, 2023 | Transphorm, Inc. | 656 0.00% of outstanding | $1,889 | Nov 20, 2023 | $8,762 |
| Nov 17, 2023 | Transphorm, Inc. | 2,188 0.00% of outstanding | $5,842 | Nov 17, 2023 | none |
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | TGAN Transphorm, Inc. | DDisposition to issuer Common Stock | -69,677 | - | - | 0 | Jun 20, 2024 |
| Jun 20, 2024 | TGAN Transphorm, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -55,000 | $0.00 | $0 | 0 | Jun 20, 2024 |
| May 22, 2024 | TGAN Transphorm, Inc. | SOpen-market sale Common Stock10b5-1 | -3,996 | $4.89 | $20k | 69,677 | May 24, 2024 |
| Apr 24, 2024 | TGAN Transphorm, Inc. | SOpen-market sale Common Stock10b5-1 | -475 | $4.85 | $2,304 | 73,673 | Apr 26, 2024 |
| Apr 20, 2024 | TGAN Transphorm, Inc. | AGrant or award Common Stock | +1,356 | $0.00 | $0 | 74,148 | Apr 23, 2024 |
| Apr 4, 2024 | TGAN Transphorm, Inc. | SOpen-market sale Common Stock10b5-1 | -766 | $4.90 | $3,753 | 72,792 | Apr 5, 2024 |
| Feb 28, 2024 | TGAN Transphorm, Inc. | SOpen-market sale Common Stock10b5-1 | -3,996 | $4.81 | $19k | 73,558 | Mar 1, 2024 |
| Jan 24, 2024 | TGAN Transphorm, Inc. | SOpen-market sale Common Stock10b5-1 | -471 | $4.82 | $2,271 | 77,554 | Jan 26, 2024 |
| Jan 20, 2024 | TGAN Transphorm, Inc. | AGrant or award Common Stock | +1,345 | $0.00 | $0 | 78,025 | Jan 23, 2024 |
| Jan 4, 2024 | TGAN Transphorm, Inc. | SOpen-market sale Common Stock10b5-1 | -766 | $3.90 | $2,987 | 76,680 | Jan 5, 2024 |
| Jan 2, 2024 | TGAN Transphorm, Inc. | SOpen-market sale Common Stock10b5-1 | -2,187 | $3.61 | $7,895 | 77,446 | Jan 3, 2024 |
| Nov 22, 2023 | TGAN Transphorm, Inc. | SOpen-market sale Common Stock10b5-1 | -3,995 | $2.63 | $10k | 79,633 | Nov 27, 2023 |
| Nov 17, 2023 | TGAN Transphorm, Inc. | SOpen-market sale Common Stock10b5-1 | -3,227 | $2.82 | $9,094 | 84,284 | Nov 21, 2023 |
| Nov 20, 2023 | TGAN Transphorm, Inc. | SOpen-market sale Common Stock10b5-1 | -656 | $2.89 | $1,895 | 83,628 | Nov 21, 2023 |
| Oct 20, 2023 | TGAN Transphorm, Inc. | AGrant or award Common Stock | +2,708 | $0.00 | $0 | 87,511 | Oct 24, 2023 |
| Oct 11, 2023 | TGAN Transphorm, Inc. | AGrant or award Common Stock | +45,662 | $0.00 | $0 | 81,835 | Oct 13, 2023 |
| Oct 11, 2023 | TGAN Transphorm, Inc. | AGrant or award Common Stock | +2,968 | $0.00 | $0 | 84,803 | Oct 13, 2023 |
Questions about Kelly Smales
Answered from the filings on this page, as of the latest one.
Is Kelly Smales buying or selling?
Not in the last 12 months. Kelly Smales's latest open-market trade on SEC Form 4 was sold $20k of TGAN on May 22, 2024.
How did Kelly Smales's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kelly Smales has 0.
Where does Kelly Smales file Form 4?
Kelly Smales has filed Form 4 at TGAN (Transphorm, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.